Cathie's Ark Logo
undefined Logo

ARKG Holdings of Vertex Pharmaceuticals (VRTX) - Updated Daily

TherapeuticsGene TherapyGenomicsCRSPR Gene Editing
The Bucket Report Icon
Trader's Guide 2024Ships December 21st. Download our December Market Report and reserve your copy today.
Date
Direction
Shares
Fund Weight
Fund
November 21, 2022
SELL4.394k0.0592%ARKG
November 18, 2022
SELL10.337k0.1372%ARKG
November 17, 2022
SELL10.117k0.13%ARKG
August 29, 2022
SELL22.667k0.2346%ARKG
August 26, 2022
SELL4.400k0.0443%ARKG

Key Statistics

⚖️Weighting🧢Market Cap
2.33%$90.45b
🏋🏿‍♂️Weight Rank In ARKG🌏Country
19🇺🇸United States
🏋️‍♀️Weight Rank Across All Funds💳ARK Estimated Cost Average
45$225.49
🎫ARK Ownership Percent
0.04%

Other ETFs That Hold VRTX

Ticker
NameWeight
IBBiShares Biotechnology ETF7.42%
GNOMGlobal X Genomics & Biotechnology ETF2.17%
ARKGARK Genomic Revolution ETF1.98%
XLVHealth Care Select Sector SPDR® Fund1.68%
XBISPDR® S&P Biotech ETF1.09%
QYLDGlobal X NASDAQ 100 Covered Call ETF0.66%
QQQInvesco QQQ Trust0.64%
SPYSPDR S&P 500 ETF Trust0.24%
LABUS&P Biotech Bull 3X Shares ETF0.238%

Research Notes and Commentary for VRTX

No Research Notes Found for VRTX